An official website of the United States government
Fast diagnostic results using breath analysis are an anticipated possibility for disease diagnosis or general health screenings. Tests that do not require sending specimens to medical laboratories possess capabilities to speed patient diagnosis and protect both patient and healthcare staff from unnecessary prolonged exposure. The objective of this work was to develop testing procedures on an initial healthy subject cohort in Hawaii to act as a range-finding pilot study for characterizing the baseline of exhaled breath prior to further research. Using comprehensive two-dimensional gas chromatography (GC×GC), this study analyzed exhaled breath from a healthy adult population in Hawaii to profile the range of different volatile organic compounds (VOCs) and survey Hawaii-specific differences. The most consistently reported compounds in the breath profile of individuals were acetic acid, dimethoxymethane, benzoic acid methyl ester, and n-hexane. In comparison to other breathprinting studies, the list of compounds discovered was representative of control cohorts. This must be considered when implementing proposed breath diagnostics in new locations with increased interpersonal variation due to diversity. Further studies on larger numbers of subjects over longer periods of time will provide additional foundational data on baseline breath VOC profiles of control populations for comparison to disease-positive cohorts.
more »
« less
This content will become publicly available on September 1, 2026
Systematic comparison of methods for offline breath sampling
Harnessing the potential of exhaled breath analysis is an emerging frontier in medical diagnostics, given breath is a rich source of volatile organic compound (VOC) biomarkers for different medical conditions. A current downfall in this field, however, is the lack of standardized and widely available methods for offline sampling of exhaled VOCs. Herein, strides are taken toward the standardization of breath sampling in Tedlar bags by exploring several factors that can impact VOC heterogeneity, including tubing material, chemical composition of collection bags, breath fractionation, exhalation volume, and transfer flow rate. After bag-based sampling standardization, performance was benchmarked using two offline breath sampling methods, Tedlar bags and the Respiration Collector for In Vitro Analysis (ReCIVA). Three volunteers from the laboratory with no known respiratory diseases donated ≥ n = 5 samples collected onto adsorption tubes via each method, which were analyzed through thermal desorption (TD) coupled with gas chromatography-mass spectrometry (GC–MS). Data processing revealed a set of 15 highly reliable on-breath VOCs detected across volunteers, and most analytes (except indole) demonstrated higher sensitivity using Tedlar bags. Calculating relative standard deviation (RSD) values showed Tedlar bags were also significantly more reproducible compared to the ReCIVA (p < 0.03). Agreement between the two methods was demonstrated through correlating VOC signals with high statistical significance (R2 = 0.70), indicating both devices are well situated for biomarker discovery applications.
more »
« less
- Award ID(s):
- 1950672
- PAR ID:
- 10654625
- Publisher / Repository:
- Springer Nature
- Date Published:
- Journal Name:
- Analytical and Bioanalytical Chemistry
- Volume:
- 417
- Issue:
- 22
- ISSN:
- 1618-2642
- Page Range / eLocation ID:
- 5061 to 5076
- Format(s):
- Medium: X
- Sponsoring Org:
- National Science Foundation
More Like this
-
-
This clinical study presents a comprehensive investigation into the utility of breath analysis as a non-invasive method for the early detection of lung cancer. The study enrolled 14 lung cancer patients, 14 non-lung cancer controls with diverse medical conditions, and 3 tuberculosis (TB) patients for biomarker discovery. Matching criteria including age, gender, smoking history, and comorbidities were strictly followed to ensure reliable comparisons. A systematic breath sampling protocol utilizing a BIO-VOC sampler was employed, followed by VOC analysis using Thermal Desorption–Gas Chromatography–Mass Spectrometry (TD-GC/MS). The resulting VOC profiles were subjected to stringent statistical analysis, including Orthogonal Projections to Latent Structures—Discriminant Analysis (OPLS-DA), Kruskal–Wallis test, and Receiver Operating Characteristic (ROC) analysis. Notably, 13 VOCs exhibited statistically significant differences between lung cancer patients and controls. The combination of eight VOCs (hexanal, heptanal, octanal, benzaldehyde, undecane, phenylacetaldehyde, decanal, and benzoic acid) demonstrated substantial discriminatory power with an area under the curve (AUC) of 0.85, a sensitivity of 82%, and a specificity of 76% in the discovery set. Validation in an independent cohort yielded an AUC of 0.78, a sensitivity of 78%, and a specificity of 64%. Further analysis revealed that elevated aldehyde levels in lung cancer patients’ breath could be attributed to overactivated Alcohol Dehydrogenase (ADH) pathways in cancerous tissues. Addressing methodological challenges, this study employed a matching of physiological and pathological confounders, controlled room air samples, and standardized breath sampling techniques. Despite the limitations, this study’s findings emphasize the potential of breath analysis as a diagnostic tool for lung cancer and suggest its utility in differentiating tuberculosis from lung cancer. However, further research and validation are warranted for the translation of these findings into clinical practice.more » « less
-
Volatile organic compounds (VOCs) in urine headspace are potential biomarkers for different medical conditions, as canines can detect human diseases simply by smelling VOCs. Because dogs can detect disease-specific VOCs, gas chromatography–mass spectrometry (GC–MS) systems may be able to differentiate medical conditions with enhanced accuracy and precision, given they have unprecedented efficiency in separating, quantifying, and identifying VOCs in urine. Advancements in instrumentation have permitted the development of portable GC–MS systems that analyze VOCs at the point of care, but these are designed for environmental monitoring, emergency response, and manufacturing/processing. The purpose of this study is to repurpose the HAPSITE® ER portable GC–MS for identifying urinary VOC biomarkers. Method development focused on optimizing sample preparation, off-column conditions, and instrumental parameters that may affect performance. Once standardized, the method was used to analyze a urine standard (n = 10) to characterize intra-day reproducibility. To characterize inter-day performance, n = 3 samples each from three volunteers (and the standard) were analyzed each day for a total of four days (n = 48 samples). Results showed the method could detect VOC signals with adequate reproducibility and distinguish VOC profiles from different volunteers with 100% accuracy.more » « less
-
The objective of this study is to validate reduced graphene oxide (RGO)-based volatile organic compounds (VOC) sensors, assembled by simple and low-cost manufacturing, for the detection of disease-related VOCs in human breath using machine learning (ML) algorithms. RGO films were functionalized by four different metalloporphryins to assemble cross-sensitive chemiresistive sensors with different sensing properties. This work demonstrated how different ML algorithms affect the discrimination capabilities of RGO–based VOC sensors. In addition, an ML-based disease classifier was derived to discriminate healthy vs. unhealthy individuals based on breath sample data. The results show that our ML models could predict the presence of disease-related VOC compounds of interest with a minimum accuracy and F1-score of 91.7% and 83.3%, respectively, and discriminate chronic kidney disease breath with a high accuracy, 91.7%.more » « less
-
Detecting volatile organic compounds (VOCs) is increasingly recognized as a pivotal tool in non-invasive disease diagnostics. VOCs are metabolic byproducts, mostly found in human breath, urine, feces, and sweat, whose profiles may shift significantly due to pathological conditions. This paper presents a thorough review of the latest advancements in sensor technologies for VOC detection, with a focus on their healthcare applications. It begins by introducing VOC detection principles, followed by a review of the rapidly evolving technologies in this area. Special emphasis is given to functionalized molecularly imprinted polymer-based biochemical sensors for detecting breath biomarkers, owing to their exceptional selectivity. The discussion examines SWaP-C considerations alongside the respective advantages and disadvantages of VOC sensing technologies. The paper also tackles the principal challenges facing the field and concludes by outlining the current status and proposing directions for future research.more » « less
